MAPT and Alzheimer disease: Recent investigations into AD biomarkers have shown that apathy severity is associated with decreased cerebrospinal fluid (CSF) levels of amyloid beta (Aβ) but not with concentrations of phosphorylated tau (p-tau) [16,17].